Home

Articles from Precision Neuroscience

Precision Neuroscience Receives FDA Clearance for High-Resolution Cortical Electrode Array
Milestone Paves the Way for Commercialization, Unlocks New Research Potential
By Precision Neuroscience · Via GlobeNewswire · April 17, 2025
Precision Neuroscience Expands Clinical Research in Brain–Computer Interface Through Collaboration with Beth Israel Deaconess Medical Center
New study leverages Precision’s Layer 7 Cortical Interface for high-resolution brain mapping during craniotomy procedures
By Precision Neuroscience · Via GlobeNewswire · February 27, 2025
Precision Neuroscience Raises $102 Million to Advance AI-Powered Brain Implant
Series C Funding Round Establishes Precision as the Best-Funded Brain–Computer Interface Company After Neuralink
By Precision Neuroscience · Via GlobeNewswire · December 16, 2024
Inc. Names Precision Neuroscience to 2024 Best in Business List
The annual list recognizes the brain–computer interface company as a leader in the field and for its positive impact on society
By Precision Neuroscience · Via GlobeNewswire · December 3, 2024
Breakthrough in Brain–Computer Interface Technology: A New Era of Neural Decoding at the Society for Neuroscience Annual Meeting, Neuroscience 2024
Precision Neuroscience’s Cortical Surface Array unlocks an unprecedented view of neural patterns, poised to revolutionize neural decoding
By Precision Neuroscience · Via GlobeNewswire · October 7, 2024
Penn Medicine, Rockefeller Neuroscience Institute and Precision Neuroscience Unveil Breakthrough Neural Implant Data at the 2024 Congress of Neurological Surgeons Annual Meeting
First-of-its-kind in-human studies reveal unprecedented detail in brain signal mapping, advancing brain-computer interface technology
By Precision Neuroscience · Via GlobeNewswire · September 30, 2024
Precision Neuroscience Expands Executive Team as Brain–Computer Interface Industry Rapidly Advances
Jayme Strauss and Mike Kaswan join as Chief Clinical and Commercial Officer and Chief Financial Officer, respectively, as the company progresses toward FDA clearance
By Precision Neuroscience · Via GlobeNewswire · July 23, 2024
Precision Neuroscience Announces World Record for Number of Electrodes Placed On Human Brain
In a recent clinical study, Precision recorded human brain activity from over four thousand electrodes, allowing streaming of real-time cortical data for visualization of brain activity
By Precision Neuroscience · Via GlobeNewswire · May 28, 2024
Precision Neuroscience Names Verily Co-Founder Brian Otis as Chief Technology Officer
Otis will lead team developing brain implants for medical use
By Precision Neuroscience · Via GlobeNewswire · April 8, 2024
Precision Neuroscience Expands Clinical Research In Brain–Computer Interface
New studies at Mount Sinai Health System and Penn Medicine investigate how the brain controls movement
By Precision Neuroscience · Via GlobeNewswire · March 22, 2024
Precision Neuroscience Acquires U.S. Manufacturing Facility and Receives FDA Breakthrough Device Designation
The purchase allows the brain–computer interface company to oversee the end-to-end fabrication of its microelectrode array while iterating quickly on product development
By Precision Neuroscience · Via GlobeNewswire · October 5, 2023
Precision Neuroscience Begins First-in-Human Study of its Neural Interface Technology
The study, in partnership with West Virginia University’s Rockefeller Neuroscience Institute, represents the first time Precision’s electrode technology has been used to map human brain activity. The technology is designed to record brain activity in unprecedented detail.
By Precision Neuroscience · Via GlobeNewswire · June 6, 2023
Precision Neuroscience Raises $41 Million to Build and Scale the Next Generation of Treatments for Neurological Illnesses
The brain–computer interface company advances the industry with plans for a minimally invasive, reversible implant.
By Precision Neuroscience · Via GlobeNewswire · January 25, 2023